ghk cu and reta Stacking Retatrutide With GHK-Cu: Results & What to Expect GHK-Cu Peptide | The benefits,

placebo on the time to occurrence of a composite cardiovascular outcome (nonfatal myocardial infarction, nonfatal stroke, cardiovascular death, hospitalization or urgent visit due to heart failure) and a composite renal outcome (end-stage kidney disease, 40% sustained decline in eGFR, cardiovascular death or renal death) in 10,000 individuals with atherosclerotic cardiovascular disease and/or CKD

INGREDIENTS - Water, Butylene glycol, Dimethyl Isosorbide, Pyrrolidinyl diaminopyrimidine oxide, 1,2-Hexanediol, Oxothiazolidinecarboxylic acid, Allantoin, Panthenol, Citric acid, Rosemary oil leaf, Rosa canina fruit oil, Phenoxyethanol, Cl 42090, Paeonia Albi flora root extract, Aroma, Ethylhexyglycerin, Copper Tripeptide-1

Three of the subjects withdrew during the screening period prior to baseline, and sixteen subjects enrolled

Thompson Ray M, Weickert CS, Wyatt E, Webster MJ (2011)